title: Malaria parasite transporters as a drug-delivery strategy.
abstract: The recent characterization of the choline carrier of the malaria parasite and its role in the selective delivery of novel antimalarial drugs has reignited interest in parasite transporters as a drug-delivery strategy. In this article, we discuss these findings in relation to the wider context of developing a sustainable antimalarial-drug-development portfolio.
authors.affiliation: Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK, L35 QA. biagini@liv.ac.uk
authors.forename: Giancarlo A
authors.initials: GA
authors.lastname: Biagini
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Ward
authors.forename: Patrick G
authors.initials: PG
authors.lastname: Bray
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002462:Cell Membrane / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism / Q000469:parasitology*; D000882:Haplorhini; D006801:Humans; D008288:Malaria / Q000097:blood / Q000188:drug therapy*; D026901:Membrane Transport Proteins / Q000378:metabolism*; D010961:Plasmodium / Q000378:metabolism*
chemical_list: D000962:Antimalarials; D026901:Membrane Transport Proteins; C065637:choline transporter